Stent Studies Show Lower Restenosis Rates, Need For Larger Radiation Trials
This article was originally published in The Gray Sheet
Executive SummaryA proper evaluation of the effectiveness of radiation therapy in treating in-stent and associated restenosis would involve a large randomized clinical trial that examines large and diffuse lesions as well as small vessels, Richard Kuntz, MD, Beth Israel Deaconess Medical Center, Boston, advocated Feb. 19 at the Cardiovascular Radiation Therapy III conference.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.